| Focal adhesion |
2.22 |
1.15e-2 |
180/201 (89.55%) |
ACTN4;ACTN1;LAMC2;...
|
| ECM-receptor interaction |
2.18 |
5.76e-3 |
80/88 (90.91%) |
LAMC2;COL9A3;ITGA5;...
|
| Dilated cardiomyopathy |
2.01 |
3.84e-3 |
86/96 (89.58%) |
ITGA5;TNNC1;ADCY9;...
|
| TNF signaling pathway |
1.99 |
5.76e-3 |
103/112 (91.96%) |
CXCL3;PIK3CD;CXCL2;...
|
| Proteoglycans in cancer |
1.97 |
4.60e-3 |
172/205 (83.9%) |
PLAUR;PIK3CD;CCND1;...
|
| Mineral absorption |
1.96 |
5.76e-3 |
48/60 (80%) |
MT1M;MT1F;MT1E;...
|
| Estrogen signaling pathway |
1.94 |
6.58e-3 |
119/137 (86.86%) |
CALML5;PIK3CD;ITPR3;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
1.92 |
5.76e-3 |
70/77 (90.91%) |
ITGA5;ITGA6;DSP;...
|
| Regulation of lipolysis in adipocytes |
1.92 |
8.95e-3 |
52/55 (94.55%) |
MGLL;PIK3CD;ADCY9;...
|
| VEGF signaling pathway |
1.89 |
9.21e-3 |
50/59 (84.75%) |
PIK3CD;SPHK1;MAPK13;...
|
| AMPK signaling pathway |
1.87 |
1.15e-2 |
106/120 (88.33%) |
PFKP;PIK3CD;CCND1;...
|
| Shigellosis |
1.86 |
1.06e-2 |
180/246 (73.17%) |
ACTN4;ACTN1;PIK3CD;...
|
| Regulation of actin cytoskeleton |
1.86 |
9.74e-3 |
185/218 (84.86%) |
ACTN4;ACTN1;MYH9;...
|
| MicroRNAs in cancer |
1.84 |
1.23e-2 |
146/310 (47.1%) |
SLC7A1;PIK3CD;CCND1;...
|
| Gastric acid secretion |
1.83 |
1.15e-2 |
63/76 (82.89%) |
CALML5;ITPR3;ADCY9;...
|
| Apelin signaling pathway |
1.81 |
1.22e-2 |
117/137 (85.4%) |
SERPINE1;CALML5;CCND1;...
|
| IL-17 signaling pathway |
1.81 |
1.15e-2 |
84/94 (89.36%) |
FOSL1;CXCL3;CXCL2;...
|
| Apoptosis |
1.80 |
1.21e-2 |
126/168 (75%) |
CTSB;PIK3CD;BID;...
|
| C-type lectin receptor signaling pathway |
1.78 |
1.20e-2 |
93/104 (89.42%) |
CALML5;PIK3CD;ITPR3;...
|
| Osteoclast differentiation |
1.78 |
1.15e-2 |
117/127 (92.13%) |
FOSL1;PIK3CD;RELB;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.78 |
1.11e-2 |
97/100 (97%) |
F3;SERPINE1;PIK3CD;...
|
| Phosphatidylinositol signaling system |
1.78 |
1.07e-2 |
82/97 (84.54%) |
CALML5;PIK3CD;ITPR3;...
|
| Sphingolipid signaling pathway |
1.78 |
1.15e-2 |
106/119 (89.08%) |
PIK3CD;BID;GAB2;...
|
| Notch signaling pathway |
1.77 |
1.19e-2 |
49/59 (83.05%) |
DVL1;TLE1;NCOR2;...
|
| ErbB signaling pathway |
1.75 |
1.22e-2 |
79/85 (92.94%) |
PIK3CD;TGFA;HBEGF;...
|
| Pathogenic Escherichia coli infection |
1.75 |
1.18e-2 |
152/197 (77.16%) |
MYH9;IRAK1;EZR;...
|
| GnRH secretion |
1.75 |
1.15e-2 |
60/64 (93.75%) |
PIK3CD;ITPR3;AKT3;...
|
| Amoebiasis |
1.74 |
1.18e-2 |
99/102 (97.06%) |
ACTN4;ACTN1;LAMC2;...
|
| Inflammatory mediator regulation of TRP channels |
1.72 |
1.24e-2 |
82/98 (83.67%) |
CALML5;PIK3CD;ITPR3;...
|
| Rap1 signaling pathway |
1.72 |
1.24e-2 |
184/210 (87.62%) |
CALML5;PIK3CD;ADCY9;...
|
| Folate biosynthesis |
-1.67 |
4.93e-2 |
23/26 (88.46%) |
AKR1B10;AKR1C3
|
| Glutathione metabolism |
-1.69 |
4.45e-2 |
43/57 (75.44%) |
RRM2;PGD;HPGDS;...
|
| Mismatch repair |
-1.75 |
2.91e-2 |
22/23 (95.65%) |
LIG1;RPA2;MLH1;...
|
| Nucleotide excision repair |
-1.83 |
1.37e-2 |
40/47 (85.11%) |
POLD1;GTF2H3;RBX1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-2.08 |
1.90e-3 |
49/77 (63.64%) |
CYP2C9;UGT2B15;GSTM3;...
|
| Steroid hormone biosynthesis |
-2.17 |
0.00e+0 |
43/61 (70.49%) |
COMT;DHRS11;HSD11B2;...
|
| Oxidative phosphorylation |
-2.30 |
0.00e+0 |
93/133 (69.92%) |
ATP5MC3;NDUFC1;ATP6V0C;...
|
| Ribosome |
-2.32 |
0.00e+0 |
113/158 (71.52%) |
MRPL33;RPL27A;MRPS11;...
|
